ArticleCardiovascular diabetology2025

Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study.

Sangmo Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.